A feasibility study before a national randomised controlled trial (RCT) of radiotherapy (RT) in the treatment of patients with pT2 and pT3 (high risk) head and neck primary cutaneous squamous cell carcinoma (H & N pcSCC)

Introduction: The incidence of cutaneous squamous cell carcinoma (cSCC) continues to rise at a rate higher than any other human cancer. Current evidence is lacking regarding the role of adjuvant radiotherapy (RT) after surgery for high risk cSCC and there is widespread variation in practice across the UK.
Source: The British Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Authors: Tags: 65 Source Type: research